Rilpivirine Recruiting Phase 2 Trials for Contraception / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04012931A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed
NCT03589040Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant